A new blood test approved by the U.S. Food and Drug Administration can predict imminent preeclampsia, helping pregnant women who are at risk of this severe and sometimes deadly form of high blood pressure.
The test can identify with 96% accuracy which women with sometimes-vague symptoms will develop preeclampsia within the following two weeks, The New York Times reported this week.
“It’s groundbreaking. It’s revolutionary,” Dr. Douglas Woelkers, a professor of maternal-fetal medicine at the University of California, San Diego, said of the test.
